Immune Thrombocytopenia in Children: Pathophysiology, Diagnosis and Contemporary Management; A Narrative Review
Keywords:
Immune thrombocytopenia; Pediatric ITP; Platelet destruction; AutoimmunityAbstract
Background: Immune thrombocytopenia (ITP) is an acquired disorder characterized by isolated thrombocytopenia, with a platelet count below 100 × 10⁹/L. The disease may be primary or associated with other conditions, and its clinical course varies according to age and duration. Platelet loss is not explained by a single mechanism: antiplatelet antibodies, complement activation, altered T-cell responses, and impaired megakaryocyte function may all contribute to thrombocytopenia. In children, accurate recognition of these mechanisms must be considered alongside the exclusion of alternative causes of a low platelet count.
Objective: To review the definition and classification of ITP, the mechanisms underlying immune-mediated platelet destruction and reduced platelet production, and the principal approaches to diagnostic assessment, clinical evaluation, prognosis, and management described in the supplied literature chapters.
Conclusion: ITP represents a heterogeneous immune disorder in which antibody-mediated clearance, cellular immune dysregulation, and defective platelet production interact. Diagnosis remains primarily clinical and requires careful history taking, physical examination, complete blood count, peripheral blood smear review, and selective investigation for secondary causes. Disease duration, bleeding manifestations, and the possibility of alternative diagnoses are important considerations in assessment and follow-up. A clearer understanding of the different pathogenic pathways may support more individualized management, while the variability of clinical course emphasizes the need to interpret laboratory findings in the context of each patient.